{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:41:41Z","timestamp":1788370901067,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bj.2025.100851","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T19:47:37Z","timestamp":1743796057000},"page":"100851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrating comprehensive genomic profiling in the management of oncology patients: Applications and challenges in Taiwan"],"prefix":"10.1016","volume":"48","author":[{"given":"Chen-Yang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Kuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Yun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Wen-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-4548","authenticated-orcid":false,"given":"Wen-Chi","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2025.100851_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/cpmb.59","article-title":"Overview of next-generation sequencing technologies","volume":"122","author":"Slatko","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.bj.2025.100851_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-023-02228-x","article-title":"Comprehensive genomic profiling for oncological advancements by precision medicine","volume":"41","author":"Pankiw","year":"2023","journal-title":"Med Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3457806","article-title":"A comprehensive review of performance of next-generation sequencing platforms","author":"Pervez","year":"2022","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bj.2025.100851_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jmoldx.2017.11.010","article-title":"Assessment of capture and amplicon-based approaches for the development of a targeted next-generation sequencing pipeline to personalize lymphoma management","volume":"20","author":"Hung","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.bj.2025.100851_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12071539","article-title":"Target enrichment approaches for next-generation sequencing applications in oncology","volume":"12","author":"Singh","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.bj.2025.100851_bib6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.csbj.2019.10.004","article-title":"Applications and analysis of targeted genomic sequencing in cancer studies","volume":"17","author":"Bewicke-Copley","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.bj.2025.100851_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.bj.2025.100851_bib8","article-title":"Comprehensive review on the clinical impact of next-generation sequencing tests for the management of advanced cancer","volume":"7","author":"Gibbs","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib9","article-title":"Real-world impact of comprehensive genomic profiling on biomarker detection, receipt of therapy, and clinical outcomes in advanced non-small cell lung cancer","volume":"8","author":"Wallenta Law","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110842","article-title":"Advancements in long-read genome sequencing technologies and algorithms","volume":"116","author":"Espinosa","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.bj.2025.100851_bib11","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41467-022-31133-6","article-title":"Phasing analysis of lung cancer genomes using a long read sequencer","volume":"13","author":"Sakamoto","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2025.100851_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bj.2025.100851_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humimm.2021.02.012","article-title":"Next-generation sequencing technologies: an overview","volume":"82","author":"Hu","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bj.2025.100851_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.bj.2025.100851_bib15","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.21037\/tlcr-20-186","article-title":"Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy","volume":"9","author":"Suda","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.bj.2025.100851_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12920-021-00909-y","article-title":"Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation","volume":"14","author":"Heydt","year":"2021","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.bj.2025.100851_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10080521","article-title":"Next generation sequencing for gene fusion analysis in lung cancer: a literature review","volume":"10","author":"Bruno","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.bj.2025.100851_bib18","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","article-title":"High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with No mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden","volume":"25","author":"Benayed","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bj.2025.100851_bib19","article-title":"MET exon 14 skipping mutations in non-small-cell lung cancer: an overview of biology, clinical outcomes, and testing considerations","volume":"5","author":"Socinski","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jtho.2018.12.020","article-title":"DNA-based versus RNA-based detection of MET exon 14 skipping events in lung cancer","volume":"14","author":"Davies","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac519","article-title":"Recent advances in cancer fusion transcript detection","volume":"24","author":"Dorney","year":"2023","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.bj.2025.100851_bib22","article-title":"Improved gene fusion detection in childhood cancer diagnostics using RNA sequencing","volume":"6","author":"Hehir-Kwa","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133275","article-title":"Circulating tumor DNA-based genomic profiling assays in adult solid tumors for precision oncology: recent advancements and future challenges","volume":"14","author":"Chan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bj.2025.100851_bib24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41591-019-0690-1","article-title":"High-accuracy liquid biopsies","volume":"25","author":"Bellosillo","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2025.100851_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12885-023-10632-9","article-title":"ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial","volume":"23","author":"Kringelbach","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bj.2025.100851_bib26","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/s41591-022-01933-w","article-title":"Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial","volume":"28","author":"Peters","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2025.100851_bib27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jtho.2021.07.008","article-title":"Blood first assay screening trial (BFAST) in treatment-naive advanced or metastatic NSCLC: initial results of the phase 2 ALK-positive cohort","volume":"16","author":"Dziadziuszko","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib28","doi-asserted-by":"crossref","first-page":"9263","DOI":"10.1021\/acs.analchem.3c00998","article-title":"Size and concentration of cell-free DNA measured directly from blood plasma, without prior DNA extraction","volume":"95","author":"Boutonnet","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.bj.2025.100851_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2025.100851_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121938","article-title":"Assessing the concordance of genomic alterations between circulating-free DNA and tumour tissue in cancer patients","volume":"11","author":"Jahangiri","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bj.2025.100851_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-020-20162-8","article-title":"Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2025.100851_bib32","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.21.02615","article-title":"Using circulating tumor DNA in colorectal cancer: current and evolving practices","volume":"40","author":"Malla","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cllc.2021.09.002","article-title":"Genetic profiling of cell-free DNA from pleural effusion in advanced lung cancer as a surrogate for tumor tissue and revealed additional clinical actionable targets","volume":"23","author":"Tu","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.bj.2025.100851_bib34","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.21037\/jtd.2018.04.125","article-title":"Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens","volume":"10","author":"Liu","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.bj.2025.100851_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.712754","article-title":"Targeted sequencing of ascites and peritoneal washing fluid of patients with gastrointestinal cancers and their clinical applications and limitations","volume":"11","author":"Bae","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4143\/crt.2019.700","article-title":"Clinical implications of circulating tumor DNA from ascites and serial plasma in ovarian cancer","volume":"52","author":"Han","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.bj.2025.100851_bib37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bj.2025.100851_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.bj.2025.100851_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cgt.2015.39","article-title":"A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance","volume":"22","author":"Dietel","year":"2015","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.bj.2025.100851_bib40","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1200\/OP.22.00260","article-title":"Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small-cell lung cancer","volume":"18","author":"Ossowski","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.bj.2025.100851_bib41","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41698-024-00679-7","article-title":"Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to","volume":"8","author":"Lin","year":"2024","journal-title":"Pembrolizumab. npj Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oncolo\/oyad178","article-title":"A novel HRD signature is predictive of FOLFIRINOX benefit in metastatic pancreatic cancer","volume":"28","author":"Chen","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.bj.2025.100851_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2021.06.037","article-title":"Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: next-generation sequencing results of TRIBE2 study","volume":"155","author":"Antoniotti","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bj.2025.100851_bib45","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1158\/1078-0432.CCR-23-0090","article-title":"Tumor-agnostic precision medicine from the AACR GENIE database: clinical implications","volume":"29","author":"Gouda","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bj.2025.100851_bib46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","article-title":"Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial","volume":"16","author":"Le Tourneau","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib47","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/2159-8290.CD-16-1396","article-title":"High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial","volume":"7","author":"Massard","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bj.2025.100851_bib48","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1158\/1078-0432.CCR-17-0381","article-title":"Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial","volume":"23","author":"Harttrampf","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bj.2025.100851_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/annonc\/mdz080","article-title":"Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial","volume":"30","author":"Tr\u00e9dan","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.860711","article-title":"Targeted therapy for intractable cancer on the basis of molecular profiles: an open-label, phase II basket trial (Long March Pathway)","volume":"13","author":"Jiao","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","article-title":"Quantifying the expanding landscape of clinical actionability for patients with cancer","volume":"14","author":"Suehnholz","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bj.2025.100851_bib52","series-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae)","year":"2024"},{"key":"10.1016\/j.bj.2025.100851_bib53","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib55","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.21.02767","article-title":"Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion","volume":"40","author":"Chakravarty","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101586","article-title":"Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group","volume":"8","author":"Loong","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.bj.2025.100851_bib57","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s13063-019-3664-1","article-title":"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols","volume":"20","author":"Park","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.bj.2025.100851_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2025.100851_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cpt.88","article-title":"Innovative clinical trials: the LUNG-MAP study","volume":"97","author":"Steuer","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bj.2025.100851_bib60","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41591-023-02379-4","article-title":"The NCI-MATCH trial: lessons for precision oncology","volume":"29","author":"O\u2019Dwyer","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2025.100851_bib61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(18)30904-5","article-title":"Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study","volume":"20","author":"Meric-Bernstam","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib62","article-title":"Rationale and design of the targeted agent and profiling utilization registry (TAPUR) study","volume":"2018","author":"Mangat","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejca.2018.06.035","article-title":"A pooled analysis of published, basket trials in cancer medicine","volume":"101","author":"Hazim","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bj.2025.100851_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-med-062016-050343","article-title":"Basket studies: redefining clinical trials in the era of genome-driven oncology","volume":"69","author":"Tao","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bj.2025.100851_bib65","article-title":"The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours","volume":"36","author":"El Helali","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.bj.2025.100851_bib66","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41571-023-00824-4","article-title":"Molecular tumour boards - current and future considerations for precision oncology","volume":"20","author":"Tsimberidou","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib67","first-page":"190","article-title":"The molecular tumor board\u2014a key element of precision oncology","volume":"17","author":"Boos","year":"2024","journal-title":"memo - Mag Eur Med Onco"},{"key":"10.1016\/j.bj.2025.100851_bib68","article-title":"Molecular tumor board as a clinical tool for converting molecular data into real-world patient care","volume":"7","author":"Vingiani","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib69","article-title":"Real-world data from a molecular tumor board: improved outcomes in breast and gynecologic cancers patients with precision medicine","volume":"6","author":"Charo","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib70","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-020-18613-3","article-title":"Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy","volume":"11","author":"Kato","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2025.100851_bib71","article-title":"Clinical outcomes of molecular tumor boards: a systematic review","volume":"5","author":"Larson","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib72","series-title":"Starting from May 1st, the National Health Insurance (NHI) Payment Have Been Covering Next-Generation Sequencing for Solid Cancer and Leukemia as Part of Precision Medicine for Cancer Treatment, Benefitting over 20,000 Patients","author":"National Health Insurance","year":"2024"},{"key":"10.1016\/j.bj.2025.100851_bib73","article-title":"Taiwan Biobank: a rich biomedical research database of the Taiwanese population","volume":"2","author":"Feng","year":"2022","journal-title":"Cell Genom"},{"issue":"3","key":"10.1016\/j.bj.2025.100851_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264138","article-title":"Clinical and analytical validation of FoundationOne\u00aeCDx, a comprehensive genomic profiling assay for solid tumors","volume":"17","author":"Milbury","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2025.100851_bib75","article-title":"Comprehensive genomic profiling in multiple cancer types: a comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts","author":"Hung","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.bj.2025.100851_bib76","series-title":"Introduction of Cancer Precision Medicine and Biobank Consortium Collaboration Pilot Project","year":"2023"},{"key":"10.1016\/j.bj.2025.100851_bib77","first-page":"S1","article-title":"Accelerating patient access to next-generation sequencing in oncology: a plan of action","volume":"8","author":"Wilsdon","year":"2022","journal-title":"Value & Outcome"},{"key":"10.1016\/j.bj.2025.100851_bib78","article-title":"Clinical and economic impact of upfront next-generation sequencing for metastatic NSCLC in east Asia","volume":"3","author":"Loong","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.bj.2025.100851_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00356","article-title":"Economic impact of next-generation sequencing versus single-gene testing to detect genomic alterations in metastatic non-small-cell lung cancer using a decision analytic model","volume":"3","author":"Pennell","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bj.2025.100851_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13565","article-title":"Cost-effectiveness analysis of genetic testing and tailored first-line therapy for patients with metastatic gastrointestinal stromal tumors","volume":"3","author":"Banerjee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bj.2025.100851_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23914","article-title":"Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems","volume":"10","author":"Horgan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bj.2025.100851_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/oncolo\/oyae135","article-title":"Variants of uncertain significance in precision oncology: nuance or nuisance?","volume":"29","author":"Mellgard","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.bj.2025.100851_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bj.2025.100851_bib84","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41588-023-01465-0","article-title":"Genome-wide prediction of disease variant effects with a deep protein language model","volume":"55","author":"Brandes","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.bj.2025.100851_bib85","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bj.2025.100851_bib86","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ccell.2022.08.011","article-title":"Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future","volume":"40","author":"Akhoundova","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bj.2025.100851_bib87","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-024-02040-9","article-title":"Advances in spatial transcriptomics and its applications in cancer research","volume":"23","author":"Jin","year":"2024","journal-title":"Mol Cancer"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417025000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417025000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:51:46Z","timestamp":1761947506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417025000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2319417025000253"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2025.100851","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating comprehensive genomic profiling in the management of oncology patients: Applications and challenges in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2025.100851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100851"}}